openPR Logo
Press release

Global Ischemic Cerebral Stroke Market 2018 Analysis By Top Companies are Abbott Laboratories, Medtronic, Boston Scientific, Cordis Corporation, Philips, GE Healthcare, Stryker, Genentech, Merck, Bayer, Boehringer Ingelheim , Sanofi, Covidien plc, Johnson

Global Ischemic Cerebral Stroke Market

Global Ischemic Cerebral Stroke Market

Global Ischemic Cerebral Stroke market report provides an in-depth overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin.

The global Ischemic Cerebral Stroke market report also contains the drivers and restrains for the market that are derived from SOWT analysis, and also shows what all the recent developments, product launches, joint ventures, merges and accusations by the several key players and brands that are driving the market are by systemic company profiles.

The Global Ischemic Cerebral Stroke Market is expected to reach USD 42.17 billion by 2025, from USD 22.78 billion in 2017 growing at a CAGR of 8.0% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Download Free PDF Sample Copy of Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-ischemic-cerebral-stroke-market

Competitive Analysis:

The global ischemic cerebral stroke market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global continuous glucose monitoring market for global, Europe, North America, Asia Pacific and South America.

For instance, Stempeutics Research Pvt.,Ltd.(Bangalore) developed a drug Stempeucel which is expected to show efficient results in the forecast period leading to the growth of ischemic cerebral stroke market. Currently, Stempeucel is under phase II clinical trials for treatment of ischemic cerebral stroke.

Global Ischemic Cerebral Stroke Market By Drug Type ( Anticoagulation Therapy, Revascularization, Reperfusion, Antiplatelet, Neuroprotective), End User (Hospitals, Clinics, Palliative Care, Ambulatory Surgery Centers),Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2025

Reasons to Purchase this Report

· Current and future of Global Ischemic Cerebral Stroke Market outlook in the developed and emerging markets

· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

· Regions/countries that are expected to witness the fastest growth rates during the forecast period

· The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report

· The report includes the complete segmentation displayed above across all above mentioned countries

Major Market Competitors/Players:

Some of the major players operating in the global ischemic cerebral stroke market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V. , GE Healthcare, Stryker Corporation, Genentech, Inc., Merck & Co., Inc., Bayer AG , Boehringer Ingelheim , Sanofi, Covidien plc , Philips Healthcare, Johnson & Johnson, Penumbra, Inc., GE Healthcare, Siemens Healthcare, Hitachi, Ltd , Biogen, Daiichi Sankyo , Pfizer Inc., ThromboGenics NV, Vernalis plc, Neurotec Pharma SL.

To Avail 10% Discount On This Report Mail Us on :- sopan.gedam@databridgemarketresearch.com

Market Definition:

Ischemic cerebral stroke is the disease in which blood vessels supplies to brain are blocked due to the formation of blood clots which is a cause loss of neurologic function. The symptoms of ischemic cerebral stroke are abrupt onset of hemiparesis, quadriparesis and monoparesis, monocular visual loss, diplopia, visual field deficits, hemisensory deficits, dysarthria, facial droop, vertigo, ataxia, nystagmus, aphasia and decrease in the level of consciousness. According to the American Heart Association, in 2016, approximately 795,000 people suffered from stroke in U.S. Stroke is the major cause of approximately 130,000 people death in a year. According to the World Health Organization, 15 million people suffers stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. High blood pressure contributes to more than 12.7 million strokes worldwide wherein Europe averages approximately 650,000 stroke deaths occurred annually. In the ischemic stroke treatment drug type segment, warfarin is the highest revenue generating class of drug. Due to the increasing incidence of ischemic cerebral stoke disease worldwide drives the ischemic cerebral stroke market.

Major Market Drivers and Restraints:

• Increase in the number of cerebral stroke cases.

• High prices for AIS therapy.

• Increase prevalence of acute ischemic strokes.

• Limited availability of efficient drugs is restricting the market growth.

Market Segmentation:

• The global ischemic stroke market is segmented based on drug type, testing, end user, geography.

• Based on drug type the market is segmented into anticoagulation therapy, revascularization, reperfusion, antiplatelet, neuroprotective.
On the basis of anticoagulation therapy, the market is classified into

• Based on geography, the market report covers data points for 28 countries across multiple geographies namely North America & South
America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others

Key Developments in the Market:

• In 2015, Silk Road Medical, Inc.(U.S) got the FDA 510(K) approval for Anti-Stroke Enroute Device.

• In 2015, NeuroVive Pharmaceutical AB(Sweden), entered into collaboration with BBB therapeutics, for development of the NVP014
drug candidate used in the treatment of ischemic strokes.

Inquire Regarding This Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-ischemic-cerebral-stroke-
market

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Ischemic Cerebral Stroke Market 2018 Analysis By Top Companies are Abbott Laboratories, Medtronic, Boston Scientific, Cordis Corporation, Philips, GE Healthcare, Stryker, Genentech, Merck, Bayer, Boehringer Ingelheim , Sanofi, Covidien plc, Johnson here

News-ID: 1539074 • Views: 384

More Releases from Data Bridge Market Research

Electronic Drug Delivery Systems Industry - A Market Worth Observing Growth | Ca …
Global electronic drug delivery systems market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 15.31 Billion by 2027 growing at a CAGR of 8.8% in the above-mentioned forecast period. The growth of this market is owing to multiple factors such as rise in prevalence of diseases, technological advancement in the design of electronic
Electroencephalography Devices Market Excellent Growth By 2026| Natus Medical In …
Global Electroencephalography Devices Market Research Report: By Product Type (MRI, CT, PET, EEG, EMG, MEG, TCD, ICP, Electrodes, Sensors, Gels, Cables), Application (Diagnostics, Therapeutics), Procedure (Invasive, Non-Invasive), Disease (TBI, Stroke, Dementia, Epilepsy),Indication(Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Patent Foramen Ovale (PFO), Aortic Valve Stenosis, Others), Device Type (8-Channel EEG, 21-Channel EEG, 32-Channel EEG, 64-Channel EEG, Others), Modality (Standalone, Portable), End-Users (Hospitals, Clinics, Diagnostic Centers), Geography (North America, Europe,
DevOps Market May Set New Growth Story | CA Technologies, IBM Corp., Puppet Inc. …
Data Bridge Market Research recently published a research report titled, "DevOps Market Report, History and Forecast to 2026, Breakdown Data by Manufacturers, Key Regions, Types and Application". The research report attempts to give a holistic overview of the DevOps Market by keeping the information simple, relevant, accurate, and to the point. The researchers have explained each aspect of the market thorough meticulous research and undivided attention to every topic. They
Global RFID Market Growing at a CAGR of 11.72% | Honeywell International Inc, HI …
Inclusive Insight: Global RFID Market Global RFID market is to register a healthy CAGR of 11.72% in the forecast period of 2019-2026.? RFID is an acronym for "radio frequency identification" and relates to a technique in which digital data embedded in RFID tags or smart tags is discovered by a viewer via radio waves. RFID is identical to barcoding in that the tag or label data is detected by a machine

All 5 Releases


More Releases for Stroke

Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Telemedicine Market - The Rising Number of Stroke
The global telemedicine market is anticipated to demonstrate promising growth in the coming years, according to a report published by Transparency Market Research (TMR). The market is characterized with the presence of a number of small and large players, and features a highly competitive environment. The leading vendors operating in the global telemedicine market are CISCO Systems, Inc., McKesson Corporation, Polycom Corp., and AMD Global Telemedicine. Vendors are expected to
7th International Conference on Neurological Disorders & Stroke
Greetings from Stroke Congress 2018!! We are writing to request all your presence to our CME accredited event as our eminent Speaker for the upcoming “7th International Conference on Neurological Disorders & Stroke (Stroke Congress 2018)” scheduled to be held on September 20-21, 2018 in Rome, Italy. The theme of the conference is Melioration in Innovations with advancement in Neurological disorders and Stroke to create awareness on the current needs &
Stroke Management Market By Application Ischemic Stroke and Hemorrhagic Stroke
The advancements in technology and facilities to diagnose stroke and discovery of novel drugs will drive growth of stroke management market. Technologies such as robotic-assisted angiography or exoskeleton soft suit for rehabilitation are the upcoming future of stroke management market. Moreover, an idea of Mobile Stroke Treatment Units (MSTU) was introduced in Germany in 2003 and was used in Berlin for the first time in 2008. The Prehospital Acute Neurological
Intracranial Stents Sales In Global Market, 2017: By Product Types - Ischemic St …
Researchmoz added Most up-to-date research on "Intracranial Stents Sales In Global Market, 2017: By Product Types - Ischemic Stroke & Hemorrhagic Stroke" to its huge collection of research reports. This report studies sales (consumption) of Intracranial Stents in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Medtronic Stryker MicroVention?Terumo? Abbott Balt Boston Scientific Obex Medical DePuy
Rising prevalence of ischemia stroke cases in Asia-Pacific Acute Ischemic Stroke …
“Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market" research report published by Market Data Forecast estimates that the market is growing with a CAGR of 7.9% to reach USD 507.758 million by 2021, from USD 356.726 million in 2016, which amounts to a cumulative growth of USD 151.03 million. Acute ischemic strokes imply the loss of brain function in certain parts created by the lack of blood supply to the brain.